ExodusPoint Capital Management LP Buys Shares of 36,626 Phreesia, Inc. (NYSE:PHR)

ExodusPoint Capital Management LP purchased a new stake in Phreesia, Inc. (NYSE:PHR) during the first quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 36,626 shares of the company’s stock, valued at approximately $1,183,000. ExodusPoint Capital Management LP owned 0.07% of Phreesia as of its most recent filing with the SEC.

Several other large investors have also recently made changes to their positions in the stock. Envestnet Asset Management Inc. increased its holdings in Phreesia by 9.1% in the 1st quarter. Envestnet Asset Management Inc. now owns 17,263 shares of the company’s stock valued at $557,000 after purchasing an additional 1,438 shares during the last quarter. Rhumbline Advisers lifted its stake in Phreesia by 4.6% during the 1st quarter. Rhumbline Advisers now owns 80,199 shares of the company’s stock worth $2,590,000 after acquiring an additional 3,534 shares in the last quarter. Tamarack Advisers LP boosted its holdings in Phreesia by 12.3% during the 1st quarter. Tamarack Advisers LP now owns 320,000 shares of the company’s stock valued at $10,333,000 after acquiring an additional 35,000 shares during the period. Spouting Rock Asset Management LLC boosted its holdings in Phreesia by 9.0% during the 1st quarter. Spouting Rock Asset Management LLC now owns 11,163 shares of the company’s stock valued at $360,000 after acquiring an additional 924 shares during the period. Finally, Bessemer Group Inc. acquired a new position in Phreesia in the 1st quarter valued at about $127,000. 94.37% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In related news, SVP Michael J. Davidoff sold 1,075 shares of the firm’s stock in a transaction that occurred on Friday, July 21st. The stock was sold at an average price of $31.75, for a total transaction of $34,131.25. Following the transaction, the senior vice president now owns 93,576 shares in the company, valued at approximately $2,971,038. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Company insiders own 5.80% of the company’s stock.

Phreesia Stock Performance

NYSE PHR opened at $30.12 on Monday. The company has a fifty day moving average of $29.68 and a two-hundred day moving average of $31.51. The company has a debt-to-equity ratio of 0.03, a quick ratio of 2.89 and a current ratio of 2.89. Phreesia, Inc. has a 1 year low of $21.96 and a 1 year high of $40.00.

Analysts Set New Price Targets

Several analysts have recently issued reports on the stock. Canaccord Genuity Group reissued a “buy” rating and set a $46.00 price target on shares of Phreesia in a research report on Friday. Stephens reissued an “overweight” rating and issued a $37.00 price target on shares of Phreesia in a research report on Tuesday, August 15th. KeyCorp cut their price objective on Phreesia from $45.00 to $40.00 in a research report on Thursday, May 25th. Finally, Robert W. Baird reduced their price objective on Phreesia from $41.00 to $40.00 in a research note on Friday, June 2nd. Two investment analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. According to MarketBeat, Phreesia presently has a consensus rating of “Moderate Buy” and an average target price of $38.92.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. Its Phreesia Platform offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.